The Centre of Excellence in Cellular Immunotherapy (CoE CIT) is a fully-funded program that - will commit funds to co-develop and manufacture innovative, cell-based immunotherapy concepts with our partners for rapid translation into pilot clinical trials with potential for commercial outcomes.

Meet the CoE CIT teams: Leadership, Program, Clinical and Transnational Laboratory teams, as well as our Clinical and Scientific Advisory Committee (CSAC).

Over recent years, Peter Mac has maintained a substantial portfolio of CAR-T and cellular immunotherapy clinical trials, including those that are industry sponsored and investigator initiated. One of the key goals of the Centre of Excellence in Cellular Immunotherapy (CoE CIT) is to facilitate the...

CAR-T therapy is a once-off, personalised treatment that uses a patient’s own reprogrammed T-cells to fight their cancer.

The Centre of Excellence in Cellular Immunotherapy was established at the Peter Mac to collaboratively discover, develop and deliver globally competitive breakthroughs in CAR-T and other cellular immunotherapies for the treatment of cancer.